Because cell types cannot be determined using PET, PD-L1 IHC and PD-L1 PET will likely become better aligned in IHC assays that assess PD-L1 expression on tumor and immune cells using the combined positive score algorithm (75, 76). Here, CD274 is linked to neoplasm.